Fatigue visual analogue scale score correlates with quality of life in cancer patients receiving epoetin alfa (Sandoz) for chemotherapy-induced anaemia: The CIROCO study

MLA

Jerome Desramé, et al. “Fatigue Visual Analogue Scale Score Correlates with Quality of Life in Cancer Patients Receiving Epoetin Alfa (Sandoz) for Chemotherapy-Induced Anaemia: The CIROCO Study.” Cancer Treatment and Research Communications, vol. 37, no. 100781-, Jan. 2023. EBSCOhost, https://doi.org/10.1016/j.ctarc.2023.100781.

APA

Jerome Desramé, Nathalie Baize, Amélie Anota, Kamel Laribi, Laetitia Stefani, Salim Hjiej, Ekatérina Nabirotchkina, Laurent Zelek, & Sylvain Choquet. (2023). Fatigue visual analogue scale score correlates with quality of life in cancer patients receiving epoetin alfa (Sandoz) for chemotherapy-induced anaemia: The CIROCO study. Cancer Treatment and Research Communications, 37(100781-). https://doi.org/10.1016/j.ctarc.2023.100781

Chicago

Jerome Desramé, Nathalie Baize, Amélie Anota, Kamel Laribi, Laetitia Stefani, Salim Hjiej, Ekatérina Nabirotchkina, Laurent Zelek, and Sylvain Choquet. 2023. “Fatigue Visual Analogue Scale Score Correlates with Quality of Life in Cancer Patients Receiving Epoetin Alfa (Sandoz) for Chemotherapy-Induced Anaemia: The CIROCO Study.” Cancer Treatment and Research Communications 37 (100781-). doi:10.1016/j.ctarc.2023.100781.